作者: Ralf Oppenkowski , Michael Heinrich Seegenschmiedt
DOI: 10.1007/978-3-540-68943-0_33
关键词:
摘要: Radiotherapy (RT) of malignant head and neck disorders is a common widely accepted treatment option, radiogenic toxicity — most importantly the reduced production saliva, mucosal changes alteration taste an risk if final aim long-term local tumor control or even cure. The greater salivary glands are organs at in daily routine radiooncology. Thus, it appears exceptional to consider any RT indications for benign parotid disorders. required doses should be well below tolerance dose (TD) xerostomia evaluation. Rubin estimated occurrence 5% within 5 years after conventionally fractionated course with 2-Gy single 50-Gy total (i.e., TD5/5) [21]; Emami et al. defined TD5/5 value 32 Gy assuming that more than one third gland irradiated [6]. diseases provides excellent opportunity review development over long period time possibly allows revival special future.